Hyperoside is also highly acclaimed in the realm of cancer therapy (Peng et al., 2023), as it has been demonstrated to effectively impede the growth of cervical cancer cells by targeting the V-Myc myelocytomatosis viral oncogene homolog (C-MYC) gene (Guo W. et al., 2019). The gene discussed is MYC; the disease is cancer.